Over the next 20 years, more than $3.5 trillion of wealth is set to be transferred from the Baby Boomer generation to their beneficiaries. Foreseeing the administration of this wealth management as a hugely lucrative market, fintech company HUB24 (ASX: HUB) is set to acquire market leader Class Limited (ASX: CL1) at an impressive premium
Read More
Shareholders who took a punt on Argenica Therapeutics (ASX: AGN) when they made their market debut earlier this year will be pleased to read the Company’s roadmap to Phase 1 clinical trials. The recently-listed Company has been subjected to the trials and tribulations of being listed, with a sharp sell-down post-IPO leaving their share price
Read More
Digital payments company Novatti Group (ASX: NOV) has strengthened its capabilities in Europe with the launch of Verv, a new business payments and banking service in that market. Using Verv, customers in Europe (business and personal) are able to open a digital bank account with its own unique IBAN – International Bank Account Number –
Read More
After being one of the hardest hit stocks by the pandemic, Qantas Group (ASX: QAN) finally has some light at the end of the tunnel where they will emerge from financial ruin in a handier position following the sale of surplus land rights in the heart of Sydney for $802 million. The land is located
Read More
The magic of click and collect and home delivered meal kits was around long before COVID-19 however, the pandemic has served as an undeniable accelerator to companies like My Food Bag (ASX:MFB), a New Zealand based meal kit delivery company. The Company creates and delivers meal kits with 98% NZ ingredients and simple recipe cards
Read More
Following months of a steadily downtrending share price, things seem to be looking up for digital health company Resonance Health (ASX: RHT). Specialists in noninvasive medical imaging, the Company creates devices and software to aid in diagnosis and improve patient outcomes. Having received regulatory approval in the USA, Europe and Australia, Resonance’s products are already
Read More
Just two years ago, you probably noticed advertising in public spaces like billboards and train stations. But with the onset of a pandemic, much of that spend has been redirected towards online mediums in response to societal changes that have sent our entire lives online. And with that shift, the significant mass of advertising spend
Read More
With a share price that has effectively doubled over the past few months and a drug pipeline beginning to snowball its successes, investors that identified Pharmaxis (ASX: PXS) early on are justifiably ecstatic. The clinical stage drug developers have had a strong start to FY22 with their lead asset, oncology drug PXS-5505 and anti-skin scarring
Read More
Despite the awkwardness of a pandemic with death being talked about more than ever, Propel Funeral Partners (ASX: PFP) have been diligently handling the sensitivity of increasing death rates which has resulted in greater demand for funeral services. For the Quarter ended 30 September 2021, Propel has reported a 13% increase in revenue compared to
Read More
